ARGENX SE is 20.2x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($53.35 B vs $2.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TARS | ARGX |
|---|---|---|
| Market cap | $2.64 B | $53.35 B |
| US-listed rank | #1904 | #306 |
| Revenue (latest FY) | $451.36M | - |
| Net income (latest FY) | -$66.00M | - |
| Net margin | -14.6% | - |
| SEC filings | 617 | 272 |
ARGENX SE is 20.2x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($53.35 B vs $2.64 B).
Full pages: Tarsus Pharmaceuticals, Inc. and ARGENX SE, or browse the full rankings.